Adamis Pharmaceuticals Coverage Initiated at StockNews.com
| ADMPDelisted Stock | USD 1.74 0.24 12.12% |
Slightly above 61% of Adamis Pharma's investor base is looking to short. The analysis of current outlook of investing in Adamis Pharma suggests that many traders are alarmed regarding Adamis Pharma's prospects. Adamis Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Adamis Pharma. Many technical investors use Adamis Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Adamis |
StockNews.com initiated coverage on shares of Adamis Pharmaceuticals in a research report sent to investors on Monday morning. The brokerage issued a hold rating on the specialty pharmaceutical companys stock. Adamis Pharmaceuticals Stock Performance Shares of Adamis Pharmaceuticals stock opened at 0.10 on Monday. The business has a 50 day moving
Read at thelincolnianonline.com
 |
Adamis Pharma Fundamental Analysis
We analyze Adamis Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adamis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adamis Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Adamis Pharma is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Adamis Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adamis Pharma stock to make a market-neutral strategy. Peer analysis of Adamis Pharma could also be used in its relative valuation, which is a method of valuing Adamis Pharma by comparing valuation metrics with similar companies.
Peers
Adamis Pharma Related Equities
| SHPH | Shuttle Pharmaceuticals | 1.15 |
| ||
| ORGO | Organogenesis Holdings | 1.26 |
| ||
| LFCR | Lifecore Biomedical | 1.86 |
| ||
| EVOK | Evoke Pharma | 2.43 |
| ||
| AQST | Aquestive Therapeutics | 2.80 |
| ||
| TLRY | Tilray | 5.52 |
|
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Adamis Stock
If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |